FOLH1 and renal cell carcinoma: Seven articles, including 90 patients (87 ccRCC, 3 other RCC subtypes), provided information on the lesion-level detection rate of PSMA PET/CT in restaging of metastatic or recurrent RCC (Fig. 3).